Johnson & Johnson's subsidiary, Kenvue Inc., completed its initial public offering (IPO) and Johnson & Johnson will receive net proceeds of $4,241 million as partial consideration for the consumer health business transferred to Kenvue.
AI Assistant
JOHNSON & JOHNSON
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.